Immunotherapy

January 7, 2025

FDA Approves Subcutaneous Immunotherapy

Charles H. Weaver, MD
August 18, 2024

ASCO 2024 – Major Advances in the Treatment of Lung Cancer

Charles H. Weaver, MD
May 4, 2024

Immunotherapy combination before surgery improves outcomes for patients with pancreatic cancer

Charles H. Weaver, MD
March 14, 2024

Checkpoint Inhibitor Immunotherapy for Treatment of Advanced Cervical Cancer

Charles H. Weaver, MD
November 11, 2023

Immunotherapy Plus TACE A New Standard for Unresectable Liver Cancer?

Charles H. Weaver, MD
June 15, 2021

Toripalimab Plus Gemcitabine/Cisplatin Significantly Delays Cancer Progression in Recurrent or Metastatic Nasopharyngeal Carcinoma

Charles H. Weaver, MD
April 9, 2021

Adjuvant Keytruda Improves Disease-Free Survival in Renal Cell Carcinoma

Charles H. Weaver, MD
March 24, 2021

Immunotherapy Treatment of Cancer

Charles H. Weaver, MD
February 11, 2021

Opdivo Treatment of Bladder Cancer

Charles H. Weaver, MD
October 3, 2020

Treatment for Stages I – III Rectal Cancer

Charles H. Weaver, MD
September 28, 2020

Opdivo – Yervoy Immunotherapy Prolongs Survival in Advanced Melanoma

Charles H. Weaver, MD
August 15, 2020

Treatment & Management of Melanoma Skin Cancers

Charles H. Weaver, MD